These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29387870)

  • 1. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
    Kim SR; Heaton H; Liu LY; King BA
    JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
    [No Abstract]   [Full Text] [Related]  

  • 2. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
    McKesey J; Pandya AG
    J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
    [No Abstract]   [Full Text] [Related]  

  • 4. Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.
    Craiglow BG; King BA
    JAMA Dermatol; 2015 Oct; 151(10):1110-2. PubMed ID: 26107994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation.
    Komnitski M; Komnitski A; Komnitski Junior A; Silva de Castro CC
    An Bras Dermatol; 2020; 95(4):473-476. PubMed ID: 32418716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repigmentation of acral vitiligo with tofacitinib combined with NB-UVB phototherapy: A case report.
    Sun XK; Xu AE
    Australas J Dermatol; 2023 Nov; 64(4):571-572. PubMed ID: 37635652
    [No Abstract]   [Full Text] [Related]  

  • 7. Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child.
    Olamiju B; Craiglow BG
    Pediatr Dermatol; 2020 Jul; 37(4):754-755. PubMed ID: 32255214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical and Maintenance Treatments for Vitiligo.
    Passeron T
    Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
    Grimes PE; Hamzavi I; Lebwohl M; Ortonne JP; Lim HW
    JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of Hypopigmentation.
    Dina Y; McKesey J; Pandya AG
    J Drugs Dermatol; 2019 Mar; 18(3):s115-s116. PubMed ID: 30909355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic treatment of vitiligo : Balance and current developments].
    Meurer M; Ceric-Dehdari P
    Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
    Asawanonda P; Charoenlap M; Korkij W
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.
    Li L; Wu Y; Li L; Sun Y; Qiu L; Gao XH; Chen HD
    Dermatol Ther; 2015; 28(3):131-4. PubMed ID: 25753514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
    Klahan S; Asawanonda P
    Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
    Korobko IV; Lomonosov KM
    Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo.
    Hayashi M; Okamura K; Abe Y; Hozumi Y; Suzuki T
    J Dermatol; 2019 Jun; 46(6):548-550. PubMed ID: 30969438
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.